| Announce Date | 12/10/2025 |
| EPS Normalized Actual | $0.15 (Miss by $-0.15) |
| EPS GAAP Actual | $0.15 (Miss by $-0.15) |
| Revenue Actual | $2.16328B |
| Revenue Surprise | Beat by $2163.28M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.26347 |
| EPS GAAP Estimate | $1.26347 |
| Revenue Estimate | $0.338415774B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 10.32489 | 1.74 | 9.85102 | 12.16205 | 1 |
| Dec 2027 | 9.729 | 1.84 | 9.41608 | 10.05244 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.5 | 3.5 | 2.16328B | 11.64% | 2163.28M |
| FQ2 2025 (Jun 2025) | 3.32 | 3.32 | 2.10243B | 8.83% | 2102.43M |
| FQ1 2025 (Mar 2025) | 2.36 | 2.36 | 1.92328B | 11.41% | 1923.28M |
| FQ4 2024 (Dec 2024) | 1 | 1 | 1.82361B | 13.35% | 1823.61M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 1.91158B | 15.95% | 1911.58M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 1.91674B | 22.39% | 1916.74M |
| FQ1 2024 (Mar 2024) | 0.56 | 0.56 | 1.70375B | 25.02% | 1703.75M |
| FQ4 2023 (Dec 2023) | 0.74 | 0.74 | 1.58023B | 31.51% | 1580.23M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.26347
Consensus Revenue Estimates
0.338415774B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.70273 | -- | 2.60574 | 2.82603 | 1 |
| FQ3 2027 (Sep 2027) | 3.06616 | -- | 2.95613 | 3.20604 | 1 |
| FQ2 2027 (Jun 2027) | 2.78442 | -- | 2.6845 | 2.91145 | 1 |
| FQ1 2027 (Mar 2027) | 2.38788 | -- | 2.30219 | 2.49682 | 1 |
| FQ4 2026 (Dec 2026) | 2.35335 | -- | 2.2689 | 2.46071 | 1 |
| FQ3 2026 (Sep 2026) | 2.55715 | -36.87 | 2.46539 | 2.67381 | 1 |
| FQ2 2026 (Jun 2026) | 2.37416 | -39.84 | 2.28896 | 2.48247 | 1 |
| FQ1 2026 (Mar 2026) | 1.26347 | -86.79 | 1.2134 | 1.28962 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.96B | -- | 2.88B | 3.06B | 1 |
| FQ3 2027 (Sep 2027) | 2.92B | -- | 2.84B | 3.02B | 1 |
| FQ2 2027 (Jun 2027) | 3.12B | -- | 3.03B | 3.23B | 1 |
| FQ1 2027 (Mar 2027) | 2.8B | -- | 2.73B | 2.9B | 1 |
| FQ4 2026 (Dec 2026) | 2.51B | -- | 2.44B | 2.6B | 1 |
| FQ3 2026 (Sep 2026) | 2.59B | 16.6 | 2.52B | 2.68B | 1 |
| FQ2 2026 (Jun 2026) | 2.55B | 17.52 | 2.48B | 2.64B | 1 |
| FQ1 2026 (Mar 2026) | 0.34B | -468.32 | 0.33B | 0.34B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
0
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.5 | 3.5 | 100% | |
| FQ2 2025 (Jun 2025) | 3.32 | 3.32 | 100% | |
| FQ1 2025 (Mar 2025) | 2.36 | 2.36 | 100% | |
| FQ4 2024 (Dec 2024) | 1 | 1 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.56 | 0.56 | 100% | |
| FQ4 2023 (Dec 2023) | 0.74 | 0.74 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $2.16B | $2163.28M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.1B | $2102.43M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.92B | $1923.28M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $1.82B | $1823.61M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.91B | $1911.58M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.92B | $1916.74M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.7B | $1703.75M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.58B | $1580.23M | 100% |